Bio swiss pharma steroids

Aug 2, 2011
Novogen Sells Consumer Health Business For $10m; Bioniche, Plasvacc Deal Falls Through; Bluechiip Gearing-Up For Commercialization; Anteo Appoints Mark Bouris Chairman; Federal Grant Underpins Vaxxas $15m For No Needle Patch; Cellmid Completes Technology Transfer, GMP Production; Up To 30% Of Votes Oppose Viralytics 29m Director Options; Leaf Appoints Ken Richards CEO, Dr Jay Hetzel Director; Orbis Takes Profit On More Acrux Shares; Australian Ethical Takes 13% Of Avita; Bone Appoints Founder Dr Roger New Chairman

Bio swiss pharma steroids

bio swiss pharma steroids

Media:

bio swiss pharma steroidsbio swiss pharma steroids